Gene · 5168
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A rare ATM variant in a Colombian family with chorea-ataxia syndrome: implications for an early diagnosis. | Neurogenetics | 2026 | 42782344 | PubTator, text mining | PubMed |
| Autotaxin as a potential biomarker in hepatic encephalopathy: Insights from a mouse model and cirrhotic patients. | Cell Mol Biol (Noisy-le-grand) | 2026 | 42758110 | PubTator, text mining | PubMed |
| Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells. | ChemMedChem | 2026 | 42675576 | PubTator, text mining | PubMed |
| Development of potent and selective ENPP1 inhibitors based on imidazo[1,2-a]pyrazine and pyrazine scaffolds for cancer immunotherapy. | Eur J Med Chem | 2026 | 42648057 | PubTator, text mining | PubMed |
| Lipoprotein(a) and calcific aortic stenosis: from inherited risk marker to therapeutic target. | Front Med (Lausanne) | 2026 | 42620888 | PubTator, text mining | PubMed |
| Role of Lipoprotein(a) in Aortic Valve Calcification: Inflammatory and Oxidative Mechanisms Involved. | Int J Mol Sci | 2026 | 42589297 | PubTator, text mining | PubMed |
| Biology and function of the autotaxin/lysophosphatidic acid axis in cancer (Review). | Mol Clin Oncol | 2026 | 42577702 | PubTator, text mining | PubMed |
| Expanded ATXN10 Alleles in Neurodegenerative Disorders: A Case Series and Review of the Literature. | Mov Disord Clin Pract | 2026 | 42569794 | PubTator, text mining | PubMed |
| Lysophosphatidylcholine and lysophosphatidic acid as key messengers in atherosclerosis: from a lipid-inflammation vicious cycle to therapeutic translation. | Front Cardiovasc Med | 2026 | 42553033 | PubTator, text mining | PubMed |
| Characterizing the impact of plasma protein levels on human brain structure and disorders leveraging integrative multi-omics analysis. | medRxiv | 2026 | 42528609 | PubTator, text mining | PubMed |
| The role of the LPC/ATX/LPA axis in metabolic dysfunction-associated steatotic liver disease. | Biochem Biophys Res Commun | 2026 | 42497836 | PubTator, text mining | PubMed |
| The Scientific Basis of Cholestatic Liver Disease and Its Symptom Complex. | Clin Liver Dis | 2026 | 42486590 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD. | JHEP Rep | 2026 | 42486350 | PubTator, text mining | PubMed |
| Efficient dual-mode liquid chromatography-tandem mass spectrometry methods for quantifying major cyanotoxins in natural water. | J Chromatogr A | 2026 | 42480260 | PubTator, text mining | PubMed |
| The LPC-ATX-LPA-LPAR Axis in Major Depressive Disorder: From PC/LPC Metabolism to Receptor-Active Lipid Signaling. | Int J Mol Sci | 2026 | 42450248 | PubTator, text mining | PubMed |
| Autotaxin inhibitors: an updated patent review (2021-present). | Expert Opin Ther Pat | 2026 | 42446875 | PubTator, text mining | PubMed |
| Deep Proteomic Analysis With Machine Learning Identifies Aqueous Humor Biomarkers of ADAMTSL4-associated Congenital Ectopia Lentis. | Invest Ophthalmol Vis Sci | 2026 | 42423409 | PubTator, text mining | PubMed |
| Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approaches. | Front Immunol | 2026 | 42396445 | PubTator, text mining | PubMed |
| M2 Macrophage-Derived ENPP2/LPA Signalling Attenuates UVB-Induced Fibroblast Photoaging via LPAR1/3. | Exp Dermatol | 2026 | 42394134 | PubTator, text mining | PubMed |
| Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank. | Clin Gastroenterol Hepatol | 2026 | 42385787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5168/papers